Winslow Evans & Crocker’s Editas Medicine EDIT Stock Holding History

Winslow Evans & Crocker’s Portfolio EDIT Stock Details EDIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	$225K	Buy	3,206 +2,200	+219%	+$90.4K	0.04%	317
2020 Q3	$28K	Hold	1,006	–	–	0.01%	562
2020 Q2	$30K	Buy	1,006 +36	+4%	+$941	0.01%	539
2020 Q1	$20K	Hold	970	–	–	0.01%	573
2019 Q4	$30K	Hold	970	–	–	0.01%	597
2019 Q3	$24K	Sell	970 -606	-38%	-$15K	0.01%	620
2019 Q2	$40K	Hold	1,576	–	–	0.01%	556
2019 Q1	$40K	Buy	1,576 +1,260	+399%	+$28.5K	0.01%	538
2018 Q4	$8K	Hold	316	–	–	﹤0.01%	805
2018 Q3	$12K	Hold	316	–	–	﹤0.01%	760
2018 Q2	$12K	Hold	316	–	–	﹤0.01%	764
2018 Q1	$10.4K	Buy	316 +150	+90%	+$5.34K	﹤0.01%	775
2017 Q4	$5.07K	Buy	+166	New	+$4.18K	﹤0.01%	925

Other funds holding EDIT

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return

Winslow Evans & Crocker's EDIT Position: Q4 2020 in Review

Winslow Evans & Crocker increased its Editas Medicine (EDIT) stake by 219% in Q4 2020, buying an estimated $90.4K and bringing the position to 3,206 shares worth $225K. The position accounts for 0.04% of the portfolio, ranked #317.

Winslow Evans & Crocker first reported a position in EDIT in Q4 2017 and has held it in 13 quarters since. 311 funds tracked by Wall St. Rank hold EDIT as of Q4 2020.

Winslow Evans & Crocker held 3,206 shares of Editas Medicine worth $225K as of Q4 2020.
Winslow Evans & Crocker bought 2,200 Editas Medicine shares in Q4 2020, an estimated $90.4K.
Editas Medicine made up 0.04% of Winslow Evans & Crocker's portfolio in Q4 2020, its #317 holding.
Winslow Evans & Crocker first reported a position in Editas Medicine in Q4 2017 and has held it in 13 quarters since.
311 funds tracked by Wall St. Rank held Editas Medicine as of Q4 2020.

Based on Winslow Evans & Crocker's 13F filing for Q4 2020, filed 3 Feb 2021.